Teen Deaglan to Battle Drug Giant ; Mother Fears Anti-Epilepsy Treatment May Have Cost Son His Eyesight
Linked as:
Summary
SEVERELY disabled teenager Deaglan Kelly has joined a legal battle against pharmaceutical giants, Aventis, over the effects of a drug he took as a toddler.
Deaglan, 17, was given the anti-epilepsy medication, Sabril, as a three year old but is now awaiting tests to discover whether the tablets damaged his sight.See the full content of this document
Extract
Teen Deaglan to Battle Drug Giant ; Mother Fears Anti-Epilepsy Treatment May Have Cost Son His Eyesight
His anxious mum Jean recalled how the youngster had screaming fits, red eyes and red nose when he took the drug and, despite reassuran...
See the full content of this document
Sponsored links
